Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo Mansur

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
CNS Spectrums|October 31, 2024
Efficacy of esketamine for perinatal depression: a systematic review and meta-analysisSabrina Wong, Gia Han Le, Angela T H Kwan, et al.
CNS Spectrums|December 10, 2024
Efficacy of esketamine for perinatal depression: a systematic review and meta-analysis - CORRIGENDUMSabrina Wong, Gia Han Le, Angela T H Kwan, et al.
Journal of Psychiatric Research|September 10, 2021
Ketamine monotherapy versus adjunctive ketamine in adults with treatment-resistant depression: Results from the Canadian Rapid Treatment Centre of ExcellenceJoshua D Di Vincenzo, Orly Lipsitz, Nelson B Rodrigues, et al.
CNS Spectrums|June 2, 2025
A systematic review of anti-suicidal effects of sedative-hypnotics and cognitive behavioral therapy for insomniaKyle Valentino, Kayla Teopiz, Sabrina Wong, et al.
International Clinical Psychopharmacology|May 10, 2024
Risk of VMAT2 inhibitors on suicidality and parkinsonism: report utilizing the United States Food and Drug Administration adverse event reporting systemSabrina Wong, Gia Han Le, Angela T H Kwan, et al.
Journal of Affective Disorders|January 16, 2025
Hepatic adverse events associated with ketamine and esketamine: A population-based disproportionality analysisAngela T H Kwan, Moiz Lakhani, Kayla M Teopiz, et al.
Expert Opinion on Drug Safety|October 31, 2017
Drug-drug interactions as a result of co-administering Δ<sup>9</sup>-THC and CBD with other psychotropic agentsCarola Rong, Nicole E Carmona, Yena L Lee, et al.
CNS Spectrums|March 12, 2021
Management of cognitive impairment in bipolar disorder: a systematic review of randomized controlled trialsJocelyn K Tamura, Isabelle P Carvalho, Lui M W Leanna, et al.
Journal of Psychopharmacology (Oxford, England)|May 17, 2023
Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youthNoah Chisamore, Kevork Danayan, Nelson B Rodrigues, et al.
Psychiatry Research|March 8, 2023
Real world effectiveness of repeated ketamine infusions for treatment-resistant depression with comorbid borderline personality disorderKevork Danayan, Noah Chisamore, Nelson B Rodrigues, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
CNS Spectrums|October 31, 2024
Efficacy of esketamine for perinatal depression: a systematic review and meta-analysisSabrina Wong, Gia Han Le, Angela T H Kwan, et al.
CNS Spectrums|December 10, 2024
Efficacy of esketamine for perinatal depression: a systematic review and meta-analysis - CORRIGENDUMSabrina Wong, Gia Han Le, Angela T H Kwan, et al.
Journal of Psychiatric Research|September 10, 2021
Ketamine monotherapy versus adjunctive ketamine in adults with treatment-resistant depression: Results from the Canadian Rapid Treatment Centre of ExcellenceJoshua D Di Vincenzo, Orly Lipsitz, Nelson B Rodrigues, et al.
CNS Spectrums|June 2, 2025
A systematic review of anti-suicidal effects of sedative-hypnotics and cognitive behavioral therapy for insomniaKyle Valentino, Kayla Teopiz, Sabrina Wong, et al.
International Clinical Psychopharmacology|May 10, 2024
Risk of VMAT2 inhibitors on suicidality and parkinsonism: report utilizing the United States Food and Drug Administration adverse event reporting systemSabrina Wong, Gia Han Le, Angela T H Kwan, et al.
Journal of Affective Disorders|January 16, 2025
Hepatic adverse events associated with ketamine and esketamine: A population-based disproportionality analysisAngela T H Kwan, Moiz Lakhani, Kayla M Teopiz, et al.
Expert Opinion on Drug Safety|October 31, 2017
Drug-drug interactions as a result of co-administering Δ<sup>9</sup>-THC and CBD with other psychotropic agentsCarola Rong, Nicole E Carmona, Yena L Lee, et al.
CNS Spectrums|March 12, 2021
Management of cognitive impairment in bipolar disorder: a systematic review of randomized controlled trialsJocelyn K Tamura, Isabelle P Carvalho, Lui M W Leanna, et al.
Journal of Psychopharmacology (Oxford, England)|May 17, 2023
Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youthNoah Chisamore, Kevork Danayan, Nelson B Rodrigues, et al.
Psychiatry Research|March 8, 2023
Real world effectiveness of repeated ketamine infusions for treatment-resistant depression with comorbid borderline personality disorderKevork Danayan, Noah Chisamore, Nelson B Rodrigues, et al.
Pageof 3